Ame Bioscience Limited

Ame Bioscience Limited, based in Coventry, UK, is a small, active company founded 21 years ago. With a single employee and £6,165 in assets, it operates from a virtual address shared by many other businesses, a fact that raises some questions. The company is led by two directors and owned by Ewing Alister Martin. It’s a regular importer, primarily dealing in optical and medical tools and devices, with its last import activity recorded three months ago in September 2021.

The company’s website, amebioscience.com, focuses heavily on rapid PCR analysis of COVID-19, offering systems, kits, and surface analysis tools. It even boasts a novel, pocket-sized point-of-care device. Beyond COVID-19 testing, the site highlights a broader service: sourcing and selling capital equipment for pharmaceutical, research, and clinical organizations, even offering to find buyers for existing equipment to generate revenue. The site also mentions a piano restoration business, a curious addition to the bioscience focus.

Financially, Ame Bioscience Limited presents a mixed picture. Cash bank on hand has plummeted 71%, dropping to £4,800, while accrued liabilities have slightly decreased to £4,400. Debtor levels have risen, and equity has decreased slightly. The company’s small size (meeting two of three criteria for a small company) helps with agility, but the sharp drop in cash reserves is concerning. While the company is exempt from an audit, the figures are unaudited, and the reliance on a single employee suggests a very lean operation. The company's financial statements are prepared in accordance with Financial Reporting Standard 102.

Registered in England/Wales under the registration number 04958410, with a registered address at CV1 2NT, England, Coventry, Union House, 111 New Union Street.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.